Shanghai, China

Jie Xue

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):

Title: Jie Xue: Innovator in Antibody Development

Introduction

Jie Xue is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. His work focuses on enhancing therapeutic options for various diseases.

Latest Patents

Jie Xue holds a patent for "Anti-TIGIT antibodies, multispecific antibodies comprising the same, and methods of using the same." This patent provides anti-TIGIT antibodies that bind to the T cell immunoreceptor with Ig and ITIM domains (TIGIT). The invention includes multispecific anti-TIGIT antibodies with binding specificity for TIGIT and one or more additional antigens. In certain embodiments, the anti-TIGIT antibodies comprise a single domain antibody that binds to TIGIT. Additionally, the one or more additional antigens may include Programmed cell death ligand 1 (PDL1).

Career Highlights

Jie Xue is associated with Shanghai Henlius Biotech Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the biotechnology sector.

Collaborations

Jie Xue collaborates with notable colleagues, including Ming Yang and Wenfeng Xu, who contribute to his research initiatives.

Conclusion

Jie Xue's contributions to antibody development exemplify the innovative spirit within the biotechnology industry. His work on anti-TIGIT antibodies is paving the way for new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…